Status:
WITHDRAWN
A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety
Lead Sponsor:
Healios K.K.
Collaborating Sponsors:
Syneos Health
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This primary purpose of this study is to determine if ATHX-105 phosphate causes weight loss over a 12-week period.
Detailed Description
The rate of obesity in adults continues to increase. Obesity affects overall health and is associated with an increased risk for diabetes, high blood pressure, coronary artery disease, osteoarthritis,...
Eligibility Criteria
Inclusion
- Obese adults with a body mass index of 30-45 kg/m2
Exclusion
- Pregnancy
- Diabetes
- Adults with serious or unstable current or past medical conditions
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00735683
Start Date
September 1 2008
End Date
April 1 2009
Last Update
June 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.